Financials

  • Market Capitalization 3.66 B
  • Employee 192
  • Founded 2015
  • CEO N/A
  • Website www.relaytx.com
  • Headquarter Delaware, United States
  • FIGI BBG00DSS08K9
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-6.38
Price to sales ratio
161.99

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1545
TLX
Telix Pharmaceuticals Limited - American Depositary Shares
11.24 USD+2.00%-1.23%+16.48%+78.13%3.81 B USD
1552
NAMS
NewAmsterdam Pharma Company N.V. - Ordinary Shares
32.26 USD-3.09%-8.12%+5.60%-11.06%3.77 B USD
1587
DNLI
Denali Therapeutics Inc. - Common Stock
22.97 USD+1.41%-10.69%+3.84%+42.05%3.65 B USD
1597
GPCR
Structure Therapeutics Inc - American Depositary Shares
48.76 USD-3.62%-8.52%+14.17%+82.35%3.47 B USD

Frequently asked questions about Relay Therapeutics, Inc. - Common Stock

What is the Relay Therapeutics, Inc. - Common Stock stock price today?

The current price of Relay Therapeutics, Inc. - Common Stock (RLAY) is 19.09. Over the past 24 hours, the stock has changed by +0.05%. Follow the RLAY chart for real-time price dynamics.

What is the stock ticker of Relay Therapeutics, Inc. - Common Stock?

Relay Therapeutics, Inc. - Common Stock trades under the ticker RLAY. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Relay Therapeutics, Inc. - Common Stock stock going up?

RLAY has changed by +3.36% over the last week, +27.35% over the last month, and +437.75% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Relay Therapeutics, Inc. - Common Stock net income for the last quarter?

Relay Therapeutics, Inc. - Common Stock reported net income of -73.29 M for the last quarter. The previous quarter showed -54.89 M, which means net income changed by -33.52%.

How many employees does Relay Therapeutics, Inc. - Common Stock have?

As of the latest available data, Relay Therapeutics, Inc. - Common Stock has 192 employees. Workforce size can provide additional context about the company's scale and operations.

What is Relay Therapeutics, Inc. - Common Stock EBITDA?

Relay Therapeutics, Inc. - Common Stock EBITDA is -78.87 M, and its EBITDA margin is -2 628.93%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Relay Therapeutics, Inc. - Common Stock stock?

You can buy Relay Therapeutics, Inc. - Common Stock (RLAY) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Relay Therapeutics, Inc. - Common Stock stock?

Investing in Relay Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RLAY chart and related analysis on metatrader.com as part of your research.

News